Contract Pharma Manufacturing & Packaging

| April 14, 2014

article image
Is your organization looking for pharmaceutical contract manufacturing and packaging? At WellSpring, we may be able to help...

Spotlight

Frontier Behavioral Health

Frontier Behavioral Health was formed in 2011 with the merger of two long-standing organizations: Spokane Mental Health (since 1970) and Family Service Spokane (since 1905). Combined, FBH has more than 100 years of experience providing behavioral healthcare services in Spokane County. FBH is the lead service provider of Crisis Response Services in the region and provides 14-hour crisis intervention services and Involuntary Treatment Act evaluations. FBH serves more than 16,000 clients a year with a staff of more than 700 and provides a full range of services to people of all ages including Children and Youth, Adults and Elders. While the majority of services are provided in an outpatient setting, FBH also operates 48 inpatient beds where Evaluation & Treatment and Stabilization services are provided. Other services provided by FBH include Peer Support, Crisis Services, services in Nursing Homes, Schools, and for the Homeless. FBH also operates a Clubhouse and Vocational Rehab/Emplo

OTHER ARTICLES

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Spotlight

Frontier Behavioral Health

Frontier Behavioral Health was formed in 2011 with the merger of two long-standing organizations: Spokane Mental Health (since 1970) and Family Service Spokane (since 1905). Combined, FBH has more than 100 years of experience providing behavioral healthcare services in Spokane County. FBH is the lead service provider of Crisis Response Services in the region and provides 14-hour crisis intervention services and Involuntary Treatment Act evaluations. FBH serves more than 16,000 clients a year with a staff of more than 700 and provides a full range of services to people of all ages including Children and Youth, Adults and Elders. While the majority of services are provided in an outpatient setting, FBH also operates 48 inpatient beds where Evaluation & Treatment and Stabilization services are provided. Other services provided by FBH include Peer Support, Crisis Services, services in Nursing Homes, Schools, and for the Homeless. FBH also operates a Clubhouse and Vocational Rehab/Emplo

Events